We are live on ! Find out more
OCEA

Ocean Biomedical, Inc. Common Stock
OCEA

Delisted

OCEA was delisted on the 23rd of April, 2025.

Back to rankings

40 hedge funds and large institutions have $106M invested in Ocean Biomedical, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

14% more funds holding

Funds holding: 35 → 40 (+5)

3% more capital invested

Capital invested by funds: $103M → $106M (+$3M)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
40
Holders Change
+5
Holders Change %
+14.29%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
6
Closed
3
Calls
$143K
Puts
–
Net Calls
+$143K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
+$8.41M
2
WP
Woodline Partners
California
+$2.29M
3
MC
Meteora Capital
Florida
+$1.41M
4
Calamos Advisors
Calamos Advisors
Illinois
+$1.27M
5
WA
Whitebox Advisors
Minnesota
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
MSU
Mizuho Securities USA
New York
-$6.68M
2
WAM
Wolverine Asset Management
Illinois
-$4.68M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$734K
4
PCM
Pinz Capital Management
New York
-$607K
5
Goldman Sachs
Goldman Sachs
New York
-$364K
Name Holding Trade Value Shares
Change 		Change in
Stake
PSAMP
26
P. Schoenfeld Asset Management (PSAM)
New York
$818K – – –
LA
27
Linden Advisors
New York
$800K – – –
LCM
28
Landscape Capital Management
New Jersey
$740K +$740K +72,600 New
AI
29
Arena Investors
New York
$562K – – –
Walleye Capital
30
Walleye Capital
New York
$545K – – –
HF
31
HRT Financial
New York
$493K -$6.12K -600 -1%
DWM
32
Dakota Wealth Management
Florida
$439K – – –
AA
33
AQR Arbitrage
Connecticut
$421K – – –
CC
34
Centiva Capital
New York
$379K – – –
Walleye Trading
35
Walleye Trading
New York
$367K – – –
HCM
36
Highbridge Capital Management
New York
$357K +$357K +35,015 New
EFI
37
EHP Funds Inc
Canada
$255K – – –
Blackstone Inc
38
Blackstone Inc
New York
$148K – – –
WAM
39
Wolverine Asset Management
Illinois
$58K -$4.68M -458,997 -99%
EC
40
Elequin Capital
New York
$3K +$2.64K +259 New
MSU
41
Mizuho Securities USA
New York
– -$6.68M -668,429 Closed
PCM
42
Pinz Capital Management
New York
– -$607K -60,000 Closed
Goldman Sachs
43
Goldman Sachs
New York
– -$364K -36,000 Closed
1
2

OCEA Hedge Fund Activity: Q3 2022 in Review

40 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q3 2022, worth a combined $106M — up 2.9% from $103M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new OCEA positions and 3 closed out — a net gain of 5 holders — while 1 added to existing stakes and 6 trimmed.

The largest buyer was Polar Asset Management Partners, opening a new position worth an estimated $8.41M. The largest seller was Mizuho Securities USA, exiting entirely with an estimated $6.68M sold.

  • 40 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q3 2022, up from 35 in Q2 2022.
  • Funds reported $106M of Ocean Biomedical, Inc. Common Stock stock for Q3 2022, up 2.9% quarter-over-quarter.
  • 8 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q3 2022 and 3 closed out, a net change of +5 holders.
  • The largest Ocean Biomedical, Inc. Common Stock buyer in Q3 2022 was Polar Asset Management Partners, an estimated $8.41M added.
  • The largest Ocean Biomedical, Inc. Common Stock seller in Q3 2022 was Mizuho Securities USA, an estimated $6.68M sold.

Based on aggregated 13F filings for Q3 2022.